viewGalan Lithium Ltd

Galan Lithium's drilling confirms exceptional lithium grades at Pata Pila

Preliminary assays indicate consistent grades in excess of 900mg/l lithium ‐ some of the highest grades reported to date from any Argentinian brine project.

Galan Lithium Ltd - Galan Lithium's drilling confirms exceptional lithium grades at Pata Pila
Multiple brine zones up to 258 metres in thickness encountered

Galan Lithium Ltd (ASX:GLN) has revealed exceptional preliminary assay results from its maiden drill hole at Pata Pila, which forms part of its Western Basin Projects on the Hombre Muerto salar in Argentina.

Western Basin Projects

The Pata Pila licence covers a large alluvial fan adjacent to Livent Corporation’s (NYSE:LVHM) tenure covering the western margin of the Hombre Muerto salar.

The drill hole intercepted several brine horizons varying from 25 metres to 258 metres in thickness and was completed at 718 metres after encountering basement at a depth of 713 metres.

Preliminary results from four samples returned consistent, high lithium grades greater than 900 mg/l (milligram/litre) with low impurity levels.

Field and laboratory test results, drill hole PP‐19‐01, Pata Pila 

These results are significant, being some of the highest‐grade results reported from any brine project in Argentina to date.

Further samples taken to the end of the hole also reported heavy brines with high specific gravity values ~1.20 and conductivities >200 mS/cm (millisiemens per centimetre).

Galan is planning to undertake double packer tests following downhole geophysics which is currently underway.

Quick facts: Galan Lithium Ltd

Price: 0.48 AUD

Market: ASX
Market Cap: $115.23 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Bionomics' positive pharmacokinetic results confirms it can begin second...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

1 day, 18 hours ago

2 min read